Moreover, IL-1R signaling through the expression of inflammatory mediators promotes cancer cell survival and stemness development (both IL-1β and IL-1α reprogram mesenchymal stem cells secrete β-catenin-inducing factors), creating a cancer stem cell niche [158]. This evidence concerns the gene IL1B and cancer.